
The Roundup MDL increased to 4,415.
Active case
Roundup® has been named in thousands of lawsuits arguing an increased risk of cancer.
Connect with an attorneyActive case
Roundup® has been named in thousands of lawsuits arguing an increased risk of cancer. People may be eligible to file a Roundup lawsuit against Monsanto and Bayer if they develop non-Hodgkin lymphoma after exposure to Roundup, which has glyphosate — a widely used herbicide — as its active ingredient. Attorneys can help sick Roundup users file a Roundup lawsuit.
People are filing lawsuits arguing Monsanto’s Roundup weed killer caused them to develop non-Hodgkin lymphoma (NHL). The plaintiffs in these cases believe Monsanto — now owned entirely by Bayer Corp. — failed to warn them that its active ingredient, glyphosate, could cause cancer.
People are filing lawsuits against Monsanto and Bayer nationwide in state and federal courts. Many of the federal cases have been consolidated into a multidistrict litigation (MDL) docket.
Plaintiffs continue to file Monsanto lawsuits as part of MDL-2741, alleging that Roundup causes cancer. If you or a loved one developed cancer related to glyphosate exposure, a Roundup attorney can help you explore your legal options.
Roundup cancer lawsuits, like many toxic exposure cases, may involve complicated terms. Below are a few terms to keep in mind while exploring your legal options.
The Roundup MDL — In re: Roundup Products Liability Litigation (MDL No. 2741) — is in the U.S. District Court for the Northern District of California. Judge Vince Chhabria is presiding over the case.
When people file many civil lawsuits against one or several defendants for similar allegations in federal court, the lawsuits may be consolidated into multidistrict litigation (MDL). This consolidation allows a single judge to preside over hundreds or thousands of claims.
The Roundup MDL was created in 2016 when plaintiffs requested consolidation of existing cases. At that time, 21 cases had been filed against Monsanto in 14 federal districts. While the court processed the MDL request, an additional 16 claims were filed in 12 federal districts.
As of April 2025, 4,415 claims are active in the Roundup MDL.
Motley Rice is proud to represent a growing number of people who’ve suffered harm from Roundup exposure. These individuals include:
If you’ve developed, or a loved one has developed, similar conditions and you believe Roundup may be the cause, don’t hesitate to reach out to a Roundup lawyer at Motley Rice. Our team can help you decide with a free consultation whether a Roundup lawsuit is right for your situation.
Attorneys with toxic exposure litigation experience can help guide you through your Roundup case. First, they can determine if you are eligible to file a claim. If you are eligible, your lawyers will help put together your case, including compiling necessary documents, medical records and then file it.
Your Roundup cancer lawyer will then see your case through the legal system. This could include going to trial and fielding settlement offers before resolution.
Roundup is a weed killer manufactured by Monsanto Company and Bayer. Farmers, landscape workers, and homeowners often use
Roundup for weed control around crops, lawns, and gardens.
Roundup’s active ingredient is glyphosate, which has been registered in the U.S. as an herbicide since 1974. Glyphosate-based herbicides are widely available in the U.S.
However, the International Agency for Research on Cancer (IARC) has stated that glyphosate is a probable carcinogen (cancer-causing substance) and can be linked to cancers such as non-Hodgkin lymphoma (NHL). IARC is an agency of the World Health Organization (WHO).
Roundup manufacturers Monsanto Company and Bayer Corp. have maintained that glyphosate is safe. Monsanto and Bayer have several glyphosate-based herbicides. But the allegations have fueled federal multidistrict litigation (MDL) and state court proceedings involving thousands of plaintiffs who claim to have developed cancer caused by Roundup weed killer.
Glyphosate is the herbicidal ingredient in Roundup that can be harmful to humans. IARC has found evidence to suggest that glyphosate may be carcinogenic.
While plants treated with glyphosate typically die within three days, it can persist in the environment and be found in people well beyond its application area.
Roundup products containing glyphosate include:
While many Roundup products contain glyphosate, not all products marketed under the label carry Roundup’s signature herbicide. Consumers can check the ingredient labels on any Roundup product to see if it contains glyphosate.
Yes, Roundup is still legal in the United States. However, Roundup formulations containing glyphosate may soon be less widely available. In 2021, Bayer announced it would begin producing some non-glyphosate Roundup products — particularly those sold in U.S. residential markets — by 2023. Bayer will continue to sell glyphosate-based products for commercial use.
Calls for a ban on glyphosate products have been domestic and worldwide. In 2017, French President Emmanuel Macron announced the French government would find alternatives for the chemical. He also said he planned to ban the chemical by 2020.
In 2020, France announced certain restrictions on glyphosate use and sale. In 2023, a French court banned two glyphosate products entirely. Other countries and locales have made similar bans.
The U.S. has not moved toward a ban because glyphosate’s status as a probable human carcinogen has been hotly debated. The U.S. Environmental Protection Agency (EPA) is reevaluating its position on glyphosate because of a change in a U.S. Ninth Circuit Court of Appeals decision.
The Court nullified a prior temporary ruling that was part of an ongoing review process on glyphosate. The process included deliberation over the continued registration and use of glyphosate. The review process will need to be reconsidered or revised based on this new court action.
The EPA does not currently recognize glyphosate as a possible human carcinogen.
Many lawsuits against Monsanto and Bayer argue that glyphosate is a health risk. While the adverse health conditions may be as mild as slight throat irritation, litigation addresses people diagnosed with non-Hodgkin lymphoma.
The National Pesticide Information Center (NPIC) has identified several possible methods of glyphosate exposure for humans. Roundup exposure pathways and resulting symptoms include:
Roundup exposure may happen by consuming contaminated food or water, or being nearby while the product is sprayed. This can affect agricultural workers, groundskeepers and bystanders.
As of right now, lawsuits are only being filed for people alleging that Roundup exposure caused their non-Hodgkin lymphoma. However, research is still being conducted on other ways glyphosate and Roundup may affect humans.
Studies have linked Roundup to cancer. One of the most commonly named injuries in Roundup lawsuits is non-Hodgkin lymphoma (NHL).
Various researchers have tried quantifying the risk of developing NHL from glyphosate exposure. One analysis from the University of Washington Department of Environmental & Occupational Health Sciences (DEOHS) found glyphosate increases the risk of NHL by 41%.
Non-Hodgkin lymphoma can manifest anywhere in the body, including the abdomen, chest, brain and skin. Symptoms can be debilitating and include, but are not limited to:
Roundup users have also reported other cancers, such as B-cell lymphomas, T-cell lymphomas, leukemia and rare subtypes of NHL.
People who have been exposed to Roundup and other glyphosate products may wish to see a doctor to set up cancer screening tests.
If you or a loved one have developed non-Hodgkin lymphoma and believe it was related to Roundup use, you have options. A Roundup lawyer can evaluate your case and discuss your options.
Since its introduction in the 1970s, Roundup has grown into one of the most widely used herbicides on the market.
More than 60% of all glyphosate use in the U.S. occurred between 2004 and 2014. The uptick in use was largely because of the introduction of genetically engineered, herbicide-tolerant seeds also developed by Monsanto.
Glyphosate’s safety has been questioned for decades. Several U.S. and global agencies have conducted studies and statistical analyses regarding glyphosate’s risks. Early evaluations in the 1980s called glyphosate “possibly carcinogenic to humans.”
In 2015, the IARC, on behalf of the WHO, re-classified glyphosate as “probably carcinogenic to humans” after extensively evaluating peer-reviewed scientific literature and data.
In 2017, various Monsanto emails and documents were brought to public attention during litigation. Internal emails showed Monsanto executives planning to recruit outside scientists to author pro-Roundup studies ghost-written by Monsanto employees.
Monsanto executive William Heydens wrote about this plan in one 2015 email. “We would be keeping the cost down by us doing the writing and they would just edit & sign their names so to speak," Heydens said. The emails also showed that Monsanto had already used this plan in a 2000 study.
Plaintiffs allege Monsanto and Bayer have failed to conduct adequate studies refuting the 2015 IARC panel’s conclusions about the product’s ability to cause cancer.
Thousands of Americans have filed Roundup lawsuits. In 2016, the court established a multidistrict litigation docket to handle many of these cases under one court.
Several large verdicts and settlements have gone in favor of Roundup victims. For example, in 2019 one California couple was awarded $86.7 million. Motley Rice did not represent the couple.
Some Monsanto Roundup decisions have involved punitive and compensatory damages. A court decides punitive damages as a way to punish defendants for harming others. Compensatory damages are meant to provide compensation for personal injury victims.
Successful Roundup litigation often hinges on the defendant’s alleged failure to warn users of the risks associated with Roundup. This is a common argument in product liability cases.
Roundup attorneys can help Roundup users with NHL collect necessary documents, file a lawsuit for them and litigate the case in court. Successful Roundup cancer lawsuits may end in a settlement agreement or verdict with an award.
Thousands of individuals have active Roundup lawsuits as part of the federal MDL or in state courts. As of January 2024, Bayer states it had more than 50,000 claims pending against it. More than 4,000 of these cases are part of the federal MDL which names Monsanto as a defendant.
Lawsuits continue to be filed against Bayer for injuries allegedly caused by Roundup.
Roundup lawyers at Motley Rice are helping clients file suits against Bayer for non-Hodgkin lymphoma diagnoses. The following timeline includes non-Motley Rice legal developments.
Settlements are agreements between the defendant (in this case, usually Bayer and Monsanto) and the plaintiffs (people claiming harm by Roundup).
Bayer Corp. has made settlement offers to multiple plaintiffs; some have accepted the offers, while others have rejected them. Plaintiffs get to decide if they want to accept or reject a settlement offer.
Bayer’s 2023 Financial Report sheds some light on how many claims have been settled. “As of January 31, 2024, Monsanto had reached settlements and/or was close to settling a substantial number of claims. Of the approximately 167,000 claims in total, approximately 113,000 have been settled or are not eligible for various reasons,” the report reads.
The report also revealed that as of December 2023, the company had provisionally set aside $6.3 billion in anticipation of potential payouts for Roundup lawsuits.
4.02.25
The Roundup MDL increased to 4,415.
3.03.25
There were still 4,414 pending actions in the Roundup MDL as of March 3, 2025.
2.04.25
The Roundup MDL in the U.S. District Court for the Northern District of California has reached 4,414 cases pending.
1.02.25
As of January 2, the amount of cases in the Roundup MDL rose to 4,400.
12.01.24
With more cases added throughout November, new Roundup lawsuits in the MDL have risen to 4,373 as of December 2, 2024.
11.15.24
The makers of Roundup won a third trial in the Philadelphia County Court of Common Pleas. Despite the setback for this plaintiff, numerous other plaintiffs have prevailed in court or settled with Monsanto.
11.12.24
Bayer reported a loss of $4.45 billion in the third quarter of 2024. Reduced sales of the company’s glyphosate-based herbicides may be partly to blame. Ongoing litigation also costs the company billions in legal fees and settlement amounts.
11.01.24
Plaintiffs continued to file Roundup product lawsuits, bringing the total number of cases in the docket to 4,355 at the start of November.
10.10.24
On October 10, 2024, Bayer and Monsanto were hit with a $78 million verdict in favor of a man with non-Hodgkin lymphoma. The injured individual said he’d used Roundup at home and work since 1992. This is one of the largest recent verdicts against the Roundup manufacturers.
10.04.24
More people affected by Roundup products filed cases, bringing the total number of actions in the MDL to 4,349 at the start of October.
09.12.24
A jury ruled in the Young v. Monsanto trial that there wasn’t enough evidence to support the plaintiff’s claims that exposure to Roundup caused their non-Hodgkin lymphoma. This marked a win for Bayer and its Monsanto division. The win doesn’t negate the possibility of fair settlements for plaintiffs in future trials against Bayer.
08.16.24
The 3rd U.S. Circuit Court of Appeals in Philadelphia ruled in favor of Bayer and Monsanto in the Schaffner v. Monsanto case. The court ruled the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state laws regulating how pesticide makers label their products.
08.01.24
The Roundup multidistrict litigation docket had 4,311 plaintiffs.
07.11.24
The EPA has declined to review the safety of glyphosate. An environmental group had submitted a request for the review in early 2024, but the agency declared the evidence insufficient to trigger the review process. Despite research and bans around the world, the EPA has yet to classify glyphosate as a likely human carcinogen.
07.10.24
A proposed ban on glyphosate in Mexico remains on hold, following pressure from the USDA and Monsanto. The ban had been scheduled for January 2024, but pressure and legal challenges pushed the date back to April 2024. However, the ban has not yet gone into effect and the date it may begin has not been confirmed.
07.10.24
The Court of Appeals of the State of Oregon ruled that a trial court had improperly barred an expert witness’ testimony. The trial court had prevented the jury from hearing testimony from Dr. Charles Benbrook about EPA regulations. This exclusion may have impacted the jury’s decision to side with Monsanto, the appeals court wrote in its decision. The Court of Appeals remanded the case for a new trial that would include Dr. Benbrook’s testimony. When a pro-defendant decision is overturned, it gives the plaintiff the opportunity to have a favorable outcome in the new trial.
01.30.24
A man who sued Bayer over a non-Hodgkin lymphoma diagnosis received a favorable decision from the jury. In addition to $225 million in compensatory damages, the jury awarded him $2 billion in punitive damages. On June 4, 2024, the judge reduced the award to $400 million without overturning the jury’s decision on the merits.
11.20.23
Four plaintiffs won their claim against Bayer in lawsuits alleging that Roundup caused non-Hodgkin lymphoma in three of the plaintiffs. The award included $1.5 billion in punitive damages and more than $60 million in compensatory damages.
11.03.23
A California jury ruled in favor of a man who developed non-Hodgkin lymphoma after decades of using Roundup. The award included $7 million in compensatory damages and $325 million in punitive damages.
10.27.23
Bayer was found liable for $175 million in damages in a Philadelphia case one week after a $1.25 million jury verdict in St. Louis. The lawsuit alleged that the plaintiff developed non-Hodgkin lymphoma after years of using Roundup. The award came with $150 million in punitive damages and $25 million in compensatory damages.
10.20.23
A jury in St. Louis, Missouri, sided with a man who alleged that exposure to Roundup caused non-Hodgkin lymphoma. The plaintiff’s team argued that the chemicals in Roundup, including glyphosate, could cause cancer. The jury’s award did not come with punitive damages.
03.23.23
A federal court agreed to the settlement terms for a class action that alleged class members overpaid for Roundup products that lacked a cancer warning label. The settlement agreement meant the lead plaintiffs were eligible for $5,000 each and more than $200,000 for expenses. The remaining 200,000 eligible class members could request payment from the settlement fund.
01.19.23
A Virginia farmworker filed a new lawsuit alleging Bayer denied her a settlement payout. The settlement came out of claims that alleged Roundup had caused non-Hodgkin lymphoma in the farmworker. Bayer denied the allegation that it rejected her from the settlement because of her citizenship status.
06.27.22
Bayer filed a petition for a writ of certiorari in a California Courts of Appeal case. The case was similar to the 9th U.S. Circuit Court of Appeals case but also challenged a punitive damage ruling. The U.S. Supreme Court denied the certiorari, which meant the verdict stood for the plaintiffs.
06.21.22
Bayer filed a petition for a writ of certiorari (request for review of a lower court decision) in 2021 in the Monsanto v. Hardeman case. Bayer appealed a decision from the 9th U.S. Circuit Court of Appeals that upheld a jury verdict for the plaintiff. However, the U.S. Supreme Court denied the petition for certiorari, exhausting the company’s appeals to strike down the verdict.
04.07.22
Bayer agreed to a settlement for a trial set to begin on April 11. This Roundup settlement agreement resolved claims by dozens of plaintiffs that were to be litigated in St. Louis. The terms of the settlement are confidential.
Here are answers to a few questions people often ask about Roundup lawsuits.
There's not currently a Roundup class action lawsuit. Instead, thousands of Roundup lawsuits are included in multidistrict litigation (MDL) in federal court.
MDL is a technique for a single federal court to oversee hundreds or thousands of similar civil claims. Unlike a class action, an MDL does not consolidate all the lawsuits into a single claim. The court can rule on matters that may impact all of the cases in an MDL, but each plaintiff has an individual claim that may result in a settlement or jury award.
To file a roundup lawsuit, you will need to prove:
Family members impacted by the injury or death of a loved one may be able to file a lawsuit on their behalf.
Speaking with a Roundup lawyer can help you understand if you are eligible to file a Roundup lawsuit.
No, it’s not too late to file a Roundup weed killer litigation. The federal MDL is still accepting claims. People may also be eligible to file a lawsuit in state courts.
If you’re curious about how to file a Roundup lymphoma lawsuit, consider speaking with a Roundup attorney at Motley Rice. Doing so as soon as possible can help you stay within filing deadlines called statutes of limitations (SOL). Once these deadlines pass, you can’t file.
Our attorneys have experience litigating toxic exposure and environmental damage cases. Our law firm has represented individuals, families, communities and states. While we seek justice for our clients, our cases also look to improve environmental standards and protections for all.
In addition to our Roundup experience, we have represented people exposed to:
We have also obtained a landmark settlement for 10 cities and counties in California that alleged three lead pigment companies created a public nuisance by exposing residents to toxic lead paint.
Important Roundup Lawsuit Updates
Key Roundup lawsuit takeaways
What is the Monsanto Roundup lawsuit?
Roundup cancer lawsuit glossary
Roundup MDL
What is Roundup?
Roundup health risks
If you or someone you love has been diagnosed with non-Hodgkin lymphoma after frequent use, skin exposure or inhalation of Roundup products, you may have a claim. For more information, complete this online form or call 1.800.768.4026.
2024 status of MDL Roundup lawsuits
Roundup Lawsuit update
Case Timeline
Frequently asked questions about the Roundup lawsuit
Motley Rice’s toxic exposure litigation experience
Call us or fill out our online form with the details of your potential case.
Our team reviews your information to assess your potential case.
Talk with us about next steps.